X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-07 | BDX | Neal Shana Carol | EVP, Chief People Officer | S - Sale+OE | $235.00 | -788 | 16,201 | -5% | -$185,180 | |||||
2024-12-19 | BDX | Garrison Michael David | EVP, Pres, Medical | S - Sale | $223.33 | -2,838 | 6,141 | -32% | -$633,811 | ||||||
| DM | 2024-12-06 | BDX | Goette Roland | EVP, Pres, EMEA | S - Sale+OE | $220.76 | -5,121 | 15,516 | -25% | -$1,130,529 | |||||
2024-12-06 | BDX | Neal Shana Carol | EVP, Chief People Officer | S - Sale | $220.49 | -1,000 | 16,989 | -6% | -$220,490 | ||||||
2024-12-05 | BDX | Shan David | EVP, Chief ISC Officer | S - Sale | $220.25 | -1,500 | 6,285 | -19% | -$330,375 | ||||||
2024-06-10 | BDX | Spoerel Thomas J | SVP,Controller, Chief Acct Off | S - Sale | $239.31 | -300 | 2,093 | -13% | -$71,793 | ||||||
2024-05-15 | BDX | Goette Roland | EVP, Pres EMEA | S - Sale | $236.74 | -3,300 | 12,493 | -21% | -$781,224 | ||||||
2024-05-13 | BDX | Goette Roland | EVP, Pres EMEA | S - Sale | $236.70 | -3,300 | 15,793 | -17% | -$781,121 | ||||||
2024-04-30 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $232.81 | -1,715 | 5,381 | -24% | -$399,269 | ||||||
2024-03-14 | BDX | Spoerel Thomas J | SVP,Controller, Chief Acct Off | S - Sale | $238.29 | -282 | 2,393 | -11% | -$67,198 | ||||||
2023-12-11 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $232.46 | -1,239 | 7,274 | -15% | -$288,018 | ||||||
2023-11-28 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $238.47 | -2,156 | 4,120 | -34% | -$514,141 | ||||||
2023-09-05 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $274.48 | -459 | 3,444 | -12% | -$125,986 | ||||||
2023-08-28 | BDX | Fraser Claire | Dir | S - Sale | $281.66 | -848 | 21,608 | -4% | -$238,848 | ||||||
| D | 2023-08-11 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale+OE | $277.85 | -2,974 | 4,199 | -41% | -$826,326 | |||||
2023-08-08 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $277.13 | -1,300 | 5,157 | -20% | -$360,269 | ||||||
2023-02-03 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $248.60 | -1,421 | 4,119 | -26% | -$353,261 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |